Form 4: Omada Health Director Acquires Shares

Omada Health Director Julie D. Klapstein acquired 698 shares of common stock through restricted stock units granted under the company's Non-Employee Director Compensation Program.

Summary

• Julie D. Klapstein, a Director at Omada Health, Inc., acquired 698 shares of common stock on April 5, 2026.
• These shares were acquired as restricted stock units (RSUs) granted under the company's Non-Employee Director Compensation Program, in lieu of retainer fees.
• Each RSU represents the right to receive one share of Common Stock.
• The settlement of these RSUs will occur on a date selected by the Reporting Person or as otherwise provided by the Program.
• Following this transaction, Klapstein beneficially owns 10,434 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the acquisition of shares by a director through a standard compensation program is a routine occurrence and does not inherently signal a significant change in the company's outlook.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition was made through a compensation program, indicating a standard practice for director remuneration.

Future Outlook

The settlement of the restricted stock units will occur on a date selected by the Reporting Person or as otherwise provided by the Program.

Industry Context

StockSavvy.ai notes that director share acquisitions, particularly through compensation programs, are common in the health tech sector as a way to align executive interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it is part of a standard compensation package.
• Employees: No direct impact mentioned.
• Management: Standard compensation practice for directors.

Next Steps

• Settlement of restricted stock units as per the Program's terms.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Director Compensation, Restricted Stock Units, Common Stock, SEC Filing